Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 454

HubSpot sets range for IPO, aiming for $120m

HubSpot, which is backed by investors including Google and Salesforce, plans to float at a price between $19 and $21 a share.

Oct 2, 2014

Rocket fails to take off after $1.8bn IPO

Rocket Internet followed compatriot Zalando on to the Frankfurt Stock Exchange today at the top of its range, only to see its shares subsequently fall.

Oct 2, 2014

Kakao and Daum close $9.4bn merger

Tencent and CyberAgent both recorded hefty exits as online messaging service Kakao joined forces with internet portal Daum in a reverse merger.

Oct 1, 2014

Zalando goes public in $664m IPO

The online fashion retailer, backed by Anders Holch Povlsen, Holtzbrinck and Tengelmann, floated near the top of its range and could raise up to $765m before the IPO closes.

Oct 1, 2014

Corporates exit Alios BioPharma in $1.75bn acquisition

Novo, Roche, GlaxoSmithKline and Novartis, all of which participated in a $41m round for Alios in April, exited the pharmaceutical company, which was bought by Johnson & Johnson.

Sep 30, 2014

Vitae aims to improve its life with $55m IPO

The pharmaceutical company, backed by Allergan and Boehringer Ingelheim, raised the cash after $109m of equity funding.

Sep 30, 2014

Millennial comes for Nexage in $107m deal

Hearst and SingTel both exited after the mobile advertising platform was acquired by Millennial Media for $107.5m.

Sep 29, 2014

Alkermes gets $37m exit from Civitas

Parkinson's disease treatment company Civitas has been bought by Acorda for $525m, weeks after it raised a $55m series C round and filed for an IPO.

Sep 27, 2014

WPP exits after Visible Technologies seen by buyers

WPP-backed analytics software company Visible Technologies has been acquired by public relations technology firms Vocus and Cision after raising $30m in funding.

Sep 26, 2014

Molecular Partners thinks bigger for $134m IPO

The Johnson & Johnson-backed Switzerland-based protein developer is looking to go public after raising almost $60m in equity funding.

Sep 24, 2014
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here